Alpha 2.0
Login Register
» Authors » Osman Yesilbas

Osman Yesilbas

Explore the profile of Osman Yesilbas including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 59
Citations 228
Followers 0
Related Specialties
Pediatrics
Endocrinology
Hematology
Top 10 Co-Authors
Esra Sevketoglu
Can Yilmaz Yozgat
Hasan Serdar Kihtir
Mey Talip Petmezci
Yilmaz Yozgat
Burcu Bursal Duramaz
Selcuk Uzuner
Hafize Otcu Temur
Nevin Hatipoglu
Hamdi Murat Yildirim
Published In
Turk Pediatri Ars
J Pediatr Intensive Care
Turk J Pediatr
Cardiol Young
J Clin Apher
Affiliations
Soon will be listed here.
Recent Articles
11.
A fatal interstitial lung disease in an anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody negative patient with juvenile dermatomyositis
Yesilbas O, Yildiz M, Yozgat C, Tahaoglu I, Yazan H, Cakir E, et al.
Turk J Pediatr . 2021 Nov; 63(5):903-908. PMID: 34738372
Background: Juvenile dermatomyositis associated interstitial lung disease, rarely seen in pediatric age groups, has adverse effects on survival. Anti-melanoma differentiation associated gene 5, one of the identified autoantibodies in juvenile...
12.
Influenza Virus Associated Pediatric Acute Respiratory Distress Syndrome: Clinical Characteristics and Outcomes
Yener N, Udurgucu M, Yilmaz R, Kendirli T, Ulgen Tekerek N, Evren G, et al.
J Trop Pediatr . 2021 Nov; 67(5). PMID: 34734291
Background And Objective: The aim of this multicenter retrospective study was to determine the clinical characteristics, treatment approaches and the course of pediatric acute respiratory distress syndrome (PARDS) which developed...
13.
Successful therapeutic plasma exchange in a case with extremely severe hypertriglyceridemia secondary to diabetic ketoacidosis concomitant with type IX glycogen storage disease
Kisioglu M, Yesilbas O, Guven B, Ceylaner S, Karaguzel G
Transfus Apher Sci . 2021 Oct; 61(1):103289. PMID: 34690074
Herein, we aimed to present a child with extremely severe hypertriglyceridemia (ESHTG) secondary to diabetic ketoacidosis concomitant with type IX glycogen storage disease (GSD). Extremely severe hypertriglyceridemia (10 700 mg/dL)...
14.
First Case of MELAS Syndrome Presenting with Local Brain Edema Requiring Decompressive Craniectomy
Yesilbas O, Sengenc E, Olbak M, Bako D, Nizam O, Seyithanoglu M, et al.
Turk Neurosurg . 2021 Oct; 32(1):155-159. PMID: 34664704
Mitochondrial encephalomyopathy, lactic acidosis, and recurrent stroke-like episodes (MELAS) syndrome is a rare but one of the most common maternally inherited multisystem disorder. Although patients with MELAS present a variable...
15.
High prevalence of multilocus pathogenic variation in neurodevelopmental disorders in the Turkish population
Mitani T, Isikay S, Gezdirici A, Gulec E, Punetha J, Fatih J, et al.
Am J Hum Genet . 2021 Sep; 108(10):1981-2005. PMID: 34582790
Neurodevelopmental disorders (NDDs) are clinically and genetically heterogenous; many such disorders are secondary to perturbation in brain development and/or function. The prevalence of NDDs is > 3%, resulting in significant...
16.
Acute Myocarditis and Eculizumab Caused Severe Cholestasis in a 17-Month-Old Child Who Has Hemolytic Uremic Syndrome Associated with Shiga Toxin-Producing
Yesilbas O, Yozgat C, Akinci N, Sonmez S, Tekin E, Talebazadeh F, et al.
J Pediatr Intensive Care . 2021 Aug; 10(3):216-220. PMID: 34395040
Cardiovascular involvement is uncommon in pediatric patients with hemolytic uremic syndrome associated with Shiga toxin-producing (STEC-HUS). In this case report we presented a case of 17-month-old toddler who had a...
17.
Role of soluble triggering receptor expressed in myeloid cells-1 in distinguishing SIRS, sepsis, and septic shock in the pediatric intensive care unit
Bursal Duramaz B, Ankay N, Yesilbas O, Kihtir H, Yozgat C, Talip Petmezci M, et al.
Arch Pediatr . 2021 Aug; 28(7):567-572. PMID: 34393025
Background: Research into new markers has been intensified for early diagnosis, prognosis, and differentiation of SIRS, sepsis, and septic shock in recent years. This study aimed to investigate the role...
18.
Neurological Manifestations of Pediatric Acute COVID Infections: A Single Center Experience
Dilber B, Gayretli Aydin Z, Yesilbas O, Sag E, Aksoy N, Gundogmus F, et al.
J Trop Pediatr . 2021 Jul; 67(3). PMID: 34254129
Background: Coronavirus disease 2019 (COVID-19) usually leads to a mild infectious disease course in children, while serious complications may occur in conjunction with both acute infection and neurological symptoms, which...
19.
The Possible Role of IVIG in the Treatment of Atrial Fibrillation Accompanied by Fulminant Myocarditis in a 12-Year-Old Pediatric Patient
Yozgat C, Yesilbas O, Uzuner S, Bayramova N, Ergun G, Nurmammadova L, et al.
Case Rep Pediatr . 2021 Jun; 2021:6689865. PMID: 34094611
Background: Fulminant myocarditis (FM) is a potentially lethal condition in children due to rapid progressive hemodynamic instability and cardiogenic shock. Patients with FM might show different clinical manifestations on emergency...
20.
The first pediatric case of hemophagocytic lymphohistiocytosis secondary to Crimean-Congo haemorrhagic fever successfully treated with therapeutic plasma exchange accompanying ribavirin and intravenous immunoglobulin
Gayretli Aydin Z, Yesilbas O, Reis G, Guven B
J Clin Apher . 2021 Jun; 36(5):780-784. PMID: 34061376
Although Crimean-Congo hemorrhagic fever (CCHF) is mild and self-limited in children, some patients may develop excessive bleeding, massive liver necrosis, and multiple organ failure associated with secondary hemophagocytic lymphohistiocytosis (HLH)...